Virax Biolabs to Present at 19th World Immune Regulation Meeting

Rhea-AI Summary

Virax Biolabs (Nasdaq: VRAX) has announced its participation in the prestigious 19th World Immune Regulation Meeting (WIRM) taking place March 12-15, 2025, in Davos, Switzerland. The company's Chief Operating Officer, Dr. Nigel McCracken, will deliver a presentation titled 'Evaluation of T cell dysfunction in post acute infection syndromes' on March 12, 2025, at 20:00 in Foyer A1 of The Congress Center.

The biotechnology company, focused on viral disease diagnosis and immune response detection, will also showcase its immune profiling products at Booth 116. Management will be available to engage with research organizations and potential customers during the event.

WIRM 2025 is set to bring together approximately 600 scientists and clinicians worldwide, featuring scientific lectures, networking opportunities, and a poster exhibition in Davos.

News Market Reaction

-7.48%

1 alert

-7.48% News Effect

On the day this news was published, VRAX declined 7.48%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

LONDON, March 5, 2025 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced that the company's management will present at the 19^th World Immune Regulation Meeting (WIRM), which will take place March 12-15, 2025, in Davos, Switzerland.

Presentation Details:

Title: Evaluation of T cell dysfunction in post acute infection syndromes
Presenter: Dr. Nigel McCracken, Chief Operating Officer at Virax Biolabs
Date: Wednesday, March 12, 2025, at 20:00
Location: Foyer A1, The Congress Center, Davos, Switzerland

Additionally, the Company will be showcasing its portfolio of immune profiling products for research use at Booth 116, and management will be available for discussions with research organizations and potential customers.

WIRM 2025 is an esteemed conference where approximately 600 scientists and clinicians from around the globe gather to discuss the latest advancements in immunology. This four-day event combines top-tier scientific lectures, informal networking, and a poster exhibition, all set against the stunning backdrop of Davos.

About Virax Biolabs Group Limited

Virax Biolabs Group Limited is an innovative biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Virax Biolabs Group Limited is currently developing T-Cell-based test technologies with the intention of providing an immunology profiling platform. T-Cell testing can be particularly effective in the diagnosis and therapeutics of post-viral syndromes such as Long COVID and other chronic conditions linked to immune dysregulation.

For more information, please visit www.viraxbiolabs.com.

Investor Relations Contact:

Russo Partners, LLC
Nic Johnson
12 West 27th Street
4th Floor
New York, NY 10001
M: 303-482-6405
nic.johnson@russopartnersllc.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting-302392440.html

SOURCE Virax Biolabs

FAQ

When and where will Virax Biolabs (VRAX) present at WIRM 2025?

Virax Biolabs will present on Wednesday, March 12, 2025, at 20:00 in Foyer A1 of The Congress Center in Davos, Switzerland.

What will be the topic of Virax Biolabs' presentation at WIRM 2025?

The presentation will focus on 'Evaluation of T cell dysfunction in post acute infection syndromes,' delivered by COO Dr. Nigel McCracken.

Where can attendees find Virax Biolabs' product showcase at WIRM 2025?

Virax Biolabs will showcase its immune profiling products at Booth 116 during the conference.

How many participants are expected at WIRM 2025 where VRAX is presenting?

Approximately 600 scientists and clinicians from around the world are expected to attend WIRM 2025 in Davos.

What products will Virax Biolabs (VRAX) showcase at WIRM 2025?

Virax Biolabs will showcase its portfolio of immune profiling products designed for research use.